1-17 of 17
doxorubicin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evidence-Based Minireview: What is the optimal timing of anti–PD-1 antibodies in relapsed classical Hodgkin lymphoma?

Pamela Blair Allen, Ann S. LaCasce
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 249–251.
https://doi.org/10.1182/hematology.2019000077
Published: 2019
Journal Articles

Management of older Hodgkin lymphoma patients

Andrew M. Evens, Jordan Carter, Kah Poh Loh, Kevin A. David
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 233–242.
https://doi.org/10.1182/hematology.2019000028
Published: 2019
Journal Articles

Where does PD-1 blockade fit in HL therapy?

Alex F. Herrera
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 213–220.
https://doi.org/10.1182/asheducation-2018.1.213
Published: 2018
Journal Articles

Risk-adapted therapy for advanced-stage Hodgkin lymphoma

Michael A. Spinner, Ranjana H. Advani
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 200–206.
https://doi.org/10.1182/asheducation-2018.1.200
Published: 2018
Journal Articles

Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution

Nancy L. Bartlett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 317–323.
https://doi.org/10.1182/asheducation-2017.1.317
Published: 2017
Journal Articles

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Marco Ruella, Pierre Soubeyran
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 432–436.
https://doi.org/10.1182/asheducation-2016.1.432
Published: 2016
Journal Articles

Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?

Peter W. M. Johnson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 316–322.
https://doi.org/10.1182/asheducation-2016.1.316
Published: 2016
Journal Articles

Double-hit lymphomas: current paradigms and novel treatment approaches

Kieron Dunleavy
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 107–112.
https://doi.org/10.1182/asheducation-2014.1.107
Published: 2014
Journal Articles

Transplantation for mantle cell lymphoma: is it the right thing to do?

Michael E. Williams
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 568–574.
https://doi.org/10.1182/asheducation-2013.1.568
Published: 2013
Journal Articles

Treatment strategies for aggressive lymphomas: what works?

Wyndham H. Wilson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 584–590.
https://doi.org/10.1182/asheducation-2013.1.584
Published: 2013
Journal Articles

Interim PET-CT in the management of diffuse large B-cell lymphoma

Craig H. Moskowitz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 397–401.
https://doi.org/10.1182/asheducation.V2012.1.397.3798512
Published: 2012
Journal Articles

Optimal Therapy of Advanced Hodgkin Lymphoma

Ranjana Advani
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 310–316.
https://doi.org/10.1182/asheducation-2011.1.310
Published: 2011
Journal Articles

The Past: What We Have Learned in the Last Decade

Peter Borchmann, Andreas Engert
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 101–107.
https://doi.org/10.1182/asheducation-2010.1.101
Published: 2010
Journal Articles

Standard therapy of advanced Hodgkin lymphoma

John Kuruvilla
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 497–506.
https://doi.org/10.1182/asheducation-2009.1.497
Published: 2009
Journal Articles

Induction Therapy in Multiple Myeloma

Jean-Luc Harousseau
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 306–312.
https://doi.org/10.1182/asheducation-2008.1.306
Published: 2008
Journal Articles

Antibody Therapy in Aggressive Lymphomas

Thomas M. Habermann
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 257–264.
https://doi.org/10.1182/asheducation-2007.1.257
Published: 2007
Journal Articles

Evolving Approaches to Primary Treatment of Hodgkin Lymphoma

Joseph M. Connors
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 239–244.
https://doi.org/10.1182/asheducation-2005.1.239
Published: 2005